Physician Assistant, Medical · Winston Salem, NC
NPI
1134104417
Since 2005
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Medical Center Blvd
Winston Salem, NC, 27157
Phone (336) 716-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,339
31 services
Medicare patients, 2024
23
Average age 60
Drug cost, 2024
$4.6M
1,819 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel C Miller was code 99214 (office e&m - established), 19 times for 17 patients. In total Rachel C Miller billed 31 services in 4 codes, and Medicare paid $1,339.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 19 | 17 | $38.82 | $737 |
By year: 2022 $1,756 for 47 services; 2023 $1,583 for 36 services; 2024 $1,339 for 31 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel C Miller prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 351 prescriptions and refills. In total Rachel C Miller wrote 1,819 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 351 | 351 | 43 | $1.5M |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 244 | 244 | 27 | $954K |
| Valacyclovir Valacyclovir Hcl | 142 | 156 | 20 | $6,495 |
| Descovy Emtricitabine/Tenofov Alafenam | 97 | 97 | Under 11 | $214K |
| Tivicay Dolutegravir Sodium | 92 | 92 | 12 | $209K |
| Dovato Dolutegravir Sodium/Lamivudine | 77 | 77 | Under 11 | $239K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 76 | 76 | Under 11 | $286K |
| Isentress Raltegravir Potassium | 64 | 65 | Under 11 | $137K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 58 | 66 | Under 11 | $265K |
| Pifeltro Doravirine | 54 | 54 | Under 11 | $98K |
| Darunavir Generic | 42 | 42 | Under 11 | $44K |
| Juluca Dolutegravir/Rilpivirine | 35 | 35 | Under 11 | $122K |
| Ritonavir Generic | 34 | 44 | Under 11 | $6,396 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 31 | 31 | Under 11 | $144K |
| Edurant Rilpivirine Hcl | 29 | 29 | Under 11 | $47K |
Brand drugs: 1,290 claims; generic drugs: 529 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rachel C Miller were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.